Neuroinflammation A Key Indicator For Alzheimer's, But Current Treatments Show Little Success In Reducing - Benzinga
benzinga.comSubmitted by benzinga3476 in health
There have been several accelerated approvals granted to treatments for patients with Alzheimer’s disease (AD) by the Food and Drug Administration (FDA) in recent months, and there are several treatments also in development.